ACE2 and COVID-19: Several potential mechanisms have been described [39] that support the hypothesis that both cardiovascular risk factors and disease increase the severity of COVID-19 [62] However, cardiovascular disease can also be a primary phenomenon in COVID-19 patients, owing to the fact that ACE2 is expressed in human heart, vascular cells, and pericytes.